lactide structure
|
Common Name | lactide | ||
---|---|---|---|---|
CAS Number | 95-96-5 | Molecular Weight | 144.125 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 285.5±15.0 °C at 760 mmHg | |
Molecular Formula | C6H8O4 | Melting Point | 116-119ºC | |
MSDS | USA | Flash Point | 150.6±18.8 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Name | 3,6-Dimethyl-1,4-dioxane-2,5-dione |
---|---|
Synonym | More Synonyms |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 285.5±15.0 °C at 760 mmHg |
Melting Point | 116-119ºC |
Molecular Formula | C6H8O4 |
Molecular Weight | 144.125 |
Flash Point | 150.6±18.8 °C |
Exact Mass | 144.042252 |
PSA | 52.60000 |
LogP | -1.45 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.429 |
Storage condition | 2~8℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H319 |
Precautionary Statements | P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi:Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S37/39 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3.0 |
RTECS | JH1100000 |
HS Code | 2934999090 |
Precursor 10 | |
---|---|
DownStream 9 | |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Magnesium amino-bis(phenolato) complexes for the ring-opening polymerization of rac-lactide.
Dalton Trans. 44 , 12365-75, (2015) Magnesium compounds of tetradentate amino-bis(phenolato) ligands, Mg[L1] (1) and Mg[L2] (2) (where [L1] = 2-pyridyl-N,N-bis(2-methylene-4-methoxy-6-tert-butylphenolato), and [L2] = dimethylaminoethyla... |
|
The influence of spray-drying parameters on phase behavior, drug distribution, and in vitro release of injectable microspheres for sustained release.
J. Pharm. Sci. 104(4) , 1451-60, (2015) For ternary solid dispersions, it is indispensable to characterize their structure, phase behavior, and the spatial distribution of the dispersed drug as this might influence the release profile and/o... |
|
Microfluidic Synthesis of Hybrid Nanoparticles with Controlled Lipid Layers: Understanding Flexibility-Regulated Cell-Nanoparticle Interaction.
ACS Nano 9 , 9912-21, (2015) The functionalized lipid shell of hybrid nanoparticles plays an important role for improving their biocompatibility and in vivo stability. Yet few efforts have been made to critically examine the shel... |
L-(-)-Dilactide |
(3S)-cis-3,6-Dimethyl-1,4-dioxane-2,5-dione |
L-(-)-Lactide |
3,6-Dimethyl-1,4-dioxane-2,5-dione |
1,4-Dioxane-2,5-dione, 3,6-dimethyl- |
EINECS 202-468-3 |
UNII:7EH08MWO6M |
L-Lactide |
MFCD00011685 |
DL-Lactide |
lactide |
(3S,6S)-(-)-3,6-Dimethyl-1,4-dioxane-2,5-dione |
Propanoic acid, 2-hydroxy-, bimol. cyclic ester |